相关实验视频
Updated: Sep 17, 2025

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
2型糖尿病的饮食干预和血糖控制:系统性审查和元分析
Anesu Marume1, Exgratia Chidoko1, Joconiah Chirenda1
1Department of Global Public Health and Family Medicine, Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe.
饮食干预显著改善了2型糖尿病 (T2DM) 的管理. 包括饮食和体育活动在内的全面的生活方式改变,为T2DM患者带来最好的血糖控制结果.
科学领域:
- 代谢健康 代谢健康
- 内分泌学 在内分泌学.
- 公共卫生 公共卫生
背景情况:
- 现代生活方式有助于非传染性疾病 (NCD),如2型糖尿病 (T2DM).
- 随着T2DM患病率的上升,全球卫生保健面临重大挑战.
- 久坐不动的行为和不良饮食是T2DM的关键驱动因素.
研究的目的:
- 评估T2DM管理中的饮食干预措施的有效性.
- 确定改善血糖控制的特定营养策略.
- 综合全球关于T2DM饮食方法的证据.
主要方法:
- 18项同行评审研究 (2010-2024) 的元分析.
- 在PubMed,Scopus和Web of Science中搜索了T2DM的饮食干预研究.
- 使用随机效应模型并使用I平方统计学评估异质性.
主要成果:
- 饮食干预表明血糖控制显著改善 (MD: -0.30%).
- 在研究中观察到高异质性 (I2 = 93.4%).
- 强化生活方式干预比仅饮食方法的影响更大 (MD: -0.25%).
结论:
- 改变生活方式,特别是改变饮食,对于T2DM管理至关重要.
- 综合生活方式干预提供优越的血糖控制好处.
- 需要可持续的,多方面的战略来支持长期的T2DM管理.
更多相关视频
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...